VistaGen Therapeutics - 53 Year Dividend History | VTGN

Historical dividend payout and yield for VistaGen Therapeutics (VTGN) since 1971. The current TTM dividend payout for VistaGen Therapeutics (VTGN) as of April 12, 2024 is $0.00. The current dividend yield for VistaGen Therapeutics as of April 12, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.132B $0.001B
VistaGen Therapeutics, Inc. is a biotechnology company. It is engaged in developing and commercializing product candidates for diseases and disorders involving the central nervous system. The company's lead product candidate consists of AV-101, is an orally available prodrug candidate in Phase II development, initially for the adjunctive treatment of major depressive disorder. VistaGen Therapeutics, Inc. is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio